AUTH/2048/9/07: Grünenthal – breach of undertaking after old Versatis ad reappeared in Pulse

📅 2007 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/2048/9/07
CompanyGrünenthal Ltd
ProductVersatis (lidocaine medicated plaster)
IssueBreach of undertaking/assurance after an old journal advertisement reappeared
Publisher/journalPulse
Old headline (previously ruled in breach)“New for burning, shooting, stabbing, pains”
Revised headline identifier“New for the burning, shooting stabbing pains of post-herpetic neuralgia”
Incorrect re-publicationsPulse editions 13 September 2007 and 20 September 2007
Correct publications after revision26 April; 3, 17 and 24 May 2007 (Pulse)
Complaint received27 September 2007
Case completed25 October 2007
Applicable Code year2008
Breach clausesClause 22
No breach clausesClause 9.1; Clause 2
SanctionsUndertaking received; Additional sanctions: Not stated
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • In an earlier case (AUTH/1960/2/07), a Versatis (lidocaine medicated plaster) journal advertisement was ruled in breach for the headline claim: “New for burning, shooting, stabbing, pains”.
  • Grünenthal gave an undertaking/assurance not to use the advertisement again (undertaking provided 3 April 2007).
  • Grünenthal (via its agency) instructed the publisher (Pulse) by email to destroy old electronic copies (PDF) and replace them with a revised version; the email explained the revised headline: “New for the burning, shooting stabbing pains of post-herpetic neuralgia”. A hard copy followed by post.
  • Pulse published the updated (compliant) advertisement in April and May 2007 (26 April; 3, 17 and 24 May).
  • Pulse later reverted to the old version and published it again in the 13 and 20 September 2007 editions.
  • Investigations indicated Pulse did not destroy the old PDF and did not follow its own internal checking procedures before print (confirmed in writing by the head of client services).
  • Grünenthal notified the publisher immediately on discovering the 13 September appearance, but it was too late to prevent the 20 September repeat.
⚖️

Outcome

  • Breach of Clause 22 ruled (breach of undertaking).
  • No breach of Clause 9.1 (high standards) ruled.
  • No breach of Clause 2 (discredit to the industry) ruled.
  • The Panel considered Grünenthal had taken steps to comply, but could have made instructions more explicit (eg, emphasising inclusion of “post-herpetic neuralgia” and explaining the change followed a Code ruling), and had not sought confirmation that the old version was destroyed.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training